Results 131 to 140 of about 100,852 (314)

COVID-19 associated pulmonary aspergillosis

open access: yesMedicina Intensiva (English Edition), 2022
Mirkan Bulğak
semanticscholar   +1 more source

Recurrent Pulmonary Infection Caused by Schizophyllum commune: A Case Report and Management of Inflammation

open access: yesRespirology Case Reports, Volume 13, Issue 7, July 2025.
Schizophyllum commune (SC), commonly known as the oyster mushroom, is a basidiomycete fungus widespread in nature. This case report documents a recurrent pulmonary infection caused by S. commune in a 59‐year‐old woman with repeated admissions for cough and sputum production.
Shuai Ren   +4 more
wiley   +1 more source

Invasive fungal infection by Aspergillus flavus in immunocompetent hosts: A case series and literature review

open access: yesMedical Mycology Case Reports, 2019
Invasive aspergillosis usually affects immunocompromised hosts with variable manifestations depending on the site of infection. In this article, we present two cases of invasive Aspergillosis in two non-immunocompromised patients; both cases had a ...
Ana María Garcia-Giraldo   +4 more
doaj  

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

open access: yes
British Journal of Haematology, EarlyView.
Emma Searle   +30 more
wiley   +1 more source

Estimated Burden of Fungal Infections in Namibia

open access: yesJournal of Fungi, 2019
Namibia is a sub-Saharan country with one of the highest HIV infection rates in the world. Although care and support services are available that cater for opportunistic infections related to HIV, the main focus is narrow and predominantly aimed at ...
Cara M. Dunaiski, David W. Denning
doaj   +1 more source

Point‐of‐care diagnosis of invasive aspergillosis in non‐neutropenic patients: Aspergillus Galactomannan Lateral Flow Assay versus Aspergillus‐specific Lateral Flow Device test in bronchoalveolar lavage

open access: yesMycoses (Berlin), 2019
We compared new Aspergillus Galactomannan Lateral Flow Assay with the newly formatted Aspergillus‐specific Lateral Flow device tests for the diagnosis of invasive pulmonary aspergillosis (IPA) in non‐neutropenic patients.
J. Jenks   +5 more
semanticscholar   +1 more source

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

open access: yesLancet. Infectious Diseases (Print), 2020
P. Koehler   +24 more
semanticscholar   +1 more source

How to make a fast diagnosis in invasive aspergillosis.

open access: yesMedical Mycology, 2019
Aspergillosis is more common among immunocompromised patients with neutropenia or immunosuppression due to corticosteroid use, and infections are typically of the lung or sinuses.
C. Lass‐Flörl
semanticscholar   +1 more source

Single‐Dose, Intravenous, and Oral Pharmacokinetics of Isavuconazole in Dogs

open access: yesJournal of Veterinary Pharmacology and Therapeutics, Volume 48, Issue 4, Page 234-240, July 2025.
ABSTRACT Isavuconazole, a triazole antifungal used in humans for invasive fungal infections, may be effective for treating canine fungal infections, although data on its use in dogs is limited. This study aimed to determine the pharmacokinetics and safety of a single dose of isavuconazole in dogs, administered both intravenously and orally. Six healthy
Yishan Kuo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy